Remove 2017 Remove Disease Remove Molecular Biology
article thumbnail

Alzheimer’s disease: driving advancements with precision medicine

Drug Target Review

How does precision neuroscience differ from traditional approaches in the treatment of neurodegenerative diseases, and what advantages does it offer? Traditionally, Alzheimer’s disease is diagnosed by clinical examination, medical history and cognitive testing. We believe we are at a breakthrough moment in Alzheimer’s disease research.

Disease 59
article thumbnail

Women in Stem with Lidia Pieri

Drug Target Review

And so, I have been the managerial co-founder and CEO of Sibylla since 2017. Sibylla’s scientific founders come from very different scientific fields that do not usually speak to each other, such as theoretical physics, molecular biology and pharmaceutical chemistry. It still blows my mind to think about it.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How organoids can redefine pre-clinical research

Drug Target Review

Moreover, their intricate 3D structure and cellular diversity offer a more precise replication of specific structures and functions, making them promising candidates in disease modelling and drug testing. CRISPR engineering in organoids for gene repair and disease modelling. Signal Transduct Target Ther [Internet]. 95: 729–38

article thumbnail

The evolution of cell therapy to address unmet medical needs

Drug Target Review

There are many opportunities to address conditions of the eye, such as retinitis pigmentosa, dry age-related macular degeneration or any of the hundreds of inherited retinal diseases. Prior to joining Lineage, Mr Culley served from August 2017 to September 2018 as interim Chief Executive Officer at Artemis Therapeutics, Inc.

article thumbnail

Gamma delta T cells: a rising star in cancer therapy

Drug Target Review

Prior to the founding of IN8bio, from 2014 to 2017, Mr Ho was the Founder and Managing Partner at AlephPoint Capital, a private healthcare investment fund. Human γδ TCR repertoires in health and disease. Mr Ho has worked in the biotechnology industry for almost 20 years. and MBA students with real-world consulting experiences.

Therapies 105
article thumbnail

F. William Studier receives the 2024 Merkin Prize in ceremony at the Broad Institute for developing technology used to produce millions of doses of COVID-19 vaccines

Broad Institute

Chan School of Public Health, lauded Studier for how the technology has enabled strategies for infectious disease control. He has a humble, self-effacing demeanor, and yet he is great at pushing people to make bold bets and to try to make the impossible possible." In a video message, Melissa J.

Vaccine 64
article thumbnail

2021 Hansen Family Award goes to Professor Kai Johnsson

The Pharma Data

Johnsson has been Director of the Chemical Biology Department at the Max Planck Institute for Medical Research in Heidelberg since 2017. The methods he has developed for the targeted labeling of proteins in living cells have revolutionized cell biology. Early Excellence in Science Awards 2020.